80
Participants
Start Date
June 18, 2024
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2026
Miltefosine
Miltefosine will be prescribed by the treating physician for a minimum of 4 weeks. If treatment response is not sufficient, treatment extension could be decided by the treating physician up to 8 weeks
RECRUITING
Africa Leprosy, Tuberculosis, Rehabilitation and Training (ALERT) Hospital, Addis Ababa
Alert Hospital, Ethiopia
OTHER
Armauer Hansen Research Institute, Ethiopia
OTHER
Uppsala University
OTHER
The Netherlands Cancer Institute
OTHER
Institute of Tropical Medicine, Belgium
OTHER